These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
5. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]
6. Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results. Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ Am J Med Genet A; 2008 Oct; 146A(19):2455-67. PubMed ID: 18785270 [TBL] [Abstract][Full Text] [Related]
7. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters. Zhang J; Lambert-Messerlian G; Palomaki GE; Canick JA Prenat Diagn; 2011 Jun; 31(6):583-8. PubMed ID: 21480302 [TBL] [Abstract][Full Text] [Related]
8. Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18. Spencer K; Crossley JA; Green K; Worthington DJ; Brownbill K; Aitken DA Prenat Diagn; 1999 Dec; 19(12):1127-34. PubMed ID: 10590430 [TBL] [Abstract][Full Text] [Related]
10. Maternal serum screening for birth defects: results of a Connecticut regional program. Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425 [TBL] [Abstract][Full Text] [Related]
11. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Benn PA; Ying J; Beazoglou T; Egan JF Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240 [TBL] [Abstract][Full Text] [Related]
12. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128 [TBL] [Abstract][Full Text] [Related]
13. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay. Talbot JA; Spencer K; Abushoufa RA Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803 [TBL] [Abstract][Full Text] [Related]
16. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738 [TBL] [Abstract][Full Text] [Related]